Breast Cancer Research

official impact factor 5.79

Highly Access Review

Recent advances in systemic therapy. Advances in neoadjuvant (primary) systemic therapy with cytotoxic agents

Michael Untch* and Gunter von Minckwitz

Breast Cancer Research 2009, 11:203 doi:10.1186/bcr2227

No comments have yet been made on this article.

Post a comment